These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 30531116

  • 1. [Schistosomiasis japonica in a patient who emigrated from China: a case report].
    Machida K, Yamada T, Shimura E, Umemura M, Onoue S, Kaneko M, Mabuchi H, Takahashi Y, Sasada Y, Saida Y.
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(12):1094-1100. PubMed ID: 30531116
    [Abstract] [Full Text] [Related]

  • 2. DNA detection of Schistosoma japonicum: diagnostic validity of a LAMP assay for low-intensity infection and effects of chemotherapy in humans.
    Xu J, Guan ZX, Zhao B, Wang YY, Cao Y, Zhang HQ, Zhu XQ, He YK, Xia CM.
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003668. PubMed ID: 25874964
    [Abstract] [Full Text] [Related]

  • 3. Schistosoma japonicum infection in the pig as a model for human schistosomiasis japonica.
    Johansen MV, Bogh HO, Nansen P, Christensen NO.
    Acta Trop; 2000 Sep 18; 76(2):85-99. PubMed ID: 10936567
    [Abstract] [Full Text] [Related]

  • 4. A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control.
    Zhou YB, Zheng HM, Jiang QW.
    Parasit Vectors; 2011 Oct 07; 4():194. PubMed ID: 21981948
    [Abstract] [Full Text] [Related]

  • 5. Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China.
    Xu X, Zhang Y, Lin D, Zhang J, Xu J, Liu YM, Hu F, Qing X, Xia C, Pan W.
    Lancet Infect Dis; 2014 Jun 07; 14(6):489-97. PubMed ID: 24656567
    [Abstract] [Full Text] [Related]

  • 6. Disappearance of specific antibodies in patients with chronic schistosomiasis japonica by treatment with praziquantel.
    Ohta N, Hosaka Y, Minai M, Hayashi M, Miki Y.
    Jpn J Med Sci Biol; 1989 Feb 07; 42(1):31-8. PubMed ID: 2506387
    [Abstract] [Full Text] [Related]

  • 7. [Schistosomiasis japonica of the liver].
    Kawashima T, Sekiya C.
    Ryoikibetsu Shokogun Shirizu; 1995 Feb 07; (7):97-9. PubMed ID: 8749426
    [No Abstract] [Full Text] [Related]

  • 8. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.
    Chen MG.
    Acta Trop; 2005 Feb 07; 96(2-3):168-76. PubMed ID: 16125657
    [Abstract] [Full Text] [Related]

  • 9. Clinical diagnosis of Schistosoma japonicum infection complicating infective endocarditis and liver cirrhosis.
    Yanagisawa S, Yuasa T, Tanaka T.
    Intern Med; 2010 Feb 07; 49(11):1001-5. PubMed ID: 20519816
    [Abstract] [Full Text] [Related]

  • 10. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
    Liang YS, Li HJ, Dai JR, Wang W, Qu GL, Tao YH, Xing YT, Li YZ, Qian K, Wei JY.
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec 07; 23(6):605-10. PubMed ID: 22379812
    [Abstract] [Full Text] [Related]

  • 11. Clinical diagnostic value of viable Schistosoma japonicum eggs detected in host tissues.
    Gu K, Li Y, Driguez P, Zeng Q, Yu X, Sun H, Cai L, He Y, Wang W, McManus DP.
    BMC Infect Dis; 2017 Apr 04; 17(1):244. PubMed ID: 28376858
    [Abstract] [Full Text] [Related]

  • 12. Research and control of advanced schistosomiasis japonica in China.
    Wu W, Feng A, Huang Y.
    Parasitol Res; 2015 Jan 04; 114(1):17-27. PubMed ID: 25403379
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of Schistosoma japonicum to praziquantel in China.
    Liang YS, Dai JR, Ning A, Yu DB, Xu XJ, Zhu YC, Coles GC.
    Trop Med Int Health; 2001 Sep 04; 6(9):707-14. PubMed ID: 11555438
    [Abstract] [Full Text] [Related]

  • 14. Long-term effectiveness of the integrated schistosomiasis control strategy with emphasis on infectious source control in China: a 10-year evaluation from 2005 to 2014.
    Wang X, Wang W, Wang P.
    Parasitol Res; 2017 Feb 04; 116(2):521-528. PubMed ID: 27812902
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbits.
    Liu YH, Qian MX, Wang XG, Jia J, Wang QN, Jiang YF, Wang RQ, Yan SH, Chen BY, Li JS.
    Chin Med J (Engl); 1986 Dec 04; 99(12):935-40. PubMed ID: 3105969
    [No Abstract] [Full Text] [Related]

  • 16. [Histological observations on schistosomula of Schistosoma japonicum in mouse lung and liver after treatment with praziquantel].
    Yang YQ, Yang HZ, Zhang CW.
    Zhongguo Yao Li Xue Bao; 1985 Dec 04; 6(4):285-7. PubMed ID: 2945377
    [No Abstract] [Full Text] [Related]

  • 17. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements.
    Li YS, Sleigh AC, Ross AG, Li Y, Williams GM, Tanner M, McManus DP.
    Trans R Soc Trop Med Hyg; 2000 Dec 04; 94(2):191-7. PubMed ID: 10897367
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity of different isolates of Schistosoma japonicum from China to praziquantel.
    He YX, Hu YQ, Yu QF.
    Southeast Asian J Trop Med Public Health; 1992 Jun 04; 23(2):261-3. PubMed ID: 1439978
    [Abstract] [Full Text] [Related]

  • 19. Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China.
    Wang W, Dai JR, Li HJ, Shen XH, Liang YS.
    Parasitology; 2010 Nov 04; 137(13):1905-12. PubMed ID: 20810006
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.